Skip to main content

Table 3 Clinical characteristics of patients with MMR deficiency and confirmed HNPCC (N = 6)

From: Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients

Patient No.

Age

Site of Colorectal Cancer

Family History

Bethesda Criteria Met

MMR Protein Deficiency by IHC

Genomic Sequencing

Nucleotide Change

Amino Acid Change

Mechanism

Stage

Adjuvant Treatment

Survival and follow-up (as of Jan 2017)

139

28

Sigmoid

Maternal grandfather had resected colon mass at age 40

Yes #1

MSH6

MSH6

c.4002-2A>Ga

n/a

Intervening sequence, RNA processing

T3 N0

Stage IIA

Clinical trial

E5202

85 m alive

170

33

Sigmoid

Father colon cancer at age < 40 y; Maternal grandmother colon cancer at age < 40

Yes #1, #4, #5

Not done

EPCAM

MLH1

MSH2

3′ terminal deletion c.1100C > A deletion exon 1

Thr367 Asn

Large deletion of 3′ EPCAM and 5′ of MSH2

T4bN0

Stage IIC

Oxaliplatin + Xeloda

65 m alive

175

43

Transverse

Father died from gastric cancer, diagnosed at 53

Yes #1

MSH2, MSH6

MSH2

c.1386 + 2 T>Cb

n/a

Intervening sequence, RNA processing

T4aN1b

Stage IIIB

Oxaliplatin

5-Fu Leucovorin

53 m (33 m since last f/u)

200

47

Sigmoid

Mother colon cancer at age 71

Yes #1

MSH6

MSH6

c.1882delT

Trp628 Glysfsc7

Premature truncation of the amino acid at position 634

T3 N0

Stage IIA

None

22 m alive

226

71

Ascending

Son colon cancer at age 47

Yes #4

MSH6

MSH6

c.1882delT

Trp628 Glysfsc7

Premature truncation of the amino acid at position 634

T3 N0

Stage IIA

None

32 m alive

275

42

Descending

Father colon cancer at age 35

Yes #1, #4

MLH1, PMS2

MLH1

c.677G > Ac

Arg226 Gln

Skipping of exon 8

T3 N0

Stage IIA

None

41 m (32 m since last f/u)

Recurrence April 2014

  1. aThe MSH6 mutation c.4002-2A > G consists of a nucleotide substitution in a non-coding intervening sequence (IVS) occurring two nucleotides from the beginning of exon 10 [30]
  2. bThe MSH2 variant c.1386 + 2 T > C consists of a nucleotide substitution in a non-coding intervening sequence (IVS) occurring two base pairs from the end of exon 8 [30]
  3. cThe germline MLH1 mutation c.677G > A consists of a nucleotide substitution immediately adjacent to intron 8 [30]